Trial NCT04607252

View at ClinicalTrials.gov 
Org. Study IDs: V01 2020-10

Last trial update was posted on 2022-04-05

MeSH Interventions

Megestrol Megestrol Acetate Metformin

MeSH Conditions

Endometrial Hyperplasia Hyperplasia

Other Conditions

Atypical Endometrial Hyperplasia

Stopping Reasons

Our clinical trial NCT03241888 showed LNG-IUS had a better treatment efficacy than Megestrol Acetate (MA) alone. The median CR time for MA group, LNG-IUS group and MA plus LNG-IUS group was 7.0±0.3 months, 4.4±1.0 months and 5.7±1.2 months.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID